Evaluation of antispasmodic and related activity in the intact dog.
D000818:Animals; D001285:Atropine / Q000494:pharmacology*; D001561:Benzilates / Q000494:pharmacology*; D004285:Dogs; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006024:Glycopyrrolate / Q000494:pharmacology; D007419:Intestinal Secretions / Q000187:drug effects; D008333:Mandelic Acids / Q000494:pharmacology; D008688:Methacholine Compounds / Q000037:antagonists & inhibitors*; D008722:Methods; D009132:Muscles / Q000494:pharmacology*; D010276:Parasympatholytics / Q000494:pharmacology*; D011413:Propantheline / Q000494:pharmacology; D011759:Pyrrolidines / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D012472:Salivation / Q000187:drug effects*; D001743:Urinary Bladder / Q000187:drug effects*; D014966:Xanthenes / Q000494:pharmacology
D001561:Benzilates; D008333:Mandelic Acids; D008688:Methacholine Compounds; D010276:Parasympatholytics; D011759:Pyrrolidines; D000644:Quaternary Ammonium Compounds; D014966:Xanthenes; D011413:Propantheline; D001285:Atropine; D006024:Glycopyrrolate